The Food and Drug Administration approved three drugs on Friday to switch from prescription status to being available over the counter: GlaxoSmithKline's (NYSE:GSK) Voltaren Arthritis Pain and two related allergy drugs from Alcon (NYSE:ALC).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,